Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Events
  4.  » 12th Alzheimer’s & Parkinson’s Drug Development Summit
Icon of a monthly calendar

12th Alzheimer’s & Parkinson’s Drug Development Summit 2024

Date: April 23-25, 2024
Location: Boston, MA

ADVANCING PATIENT-CENTRIC DRUG DELIVERY FOR ALZHEIMER’S & PARKINSON’S 

In the evolving landscape of patient-centric drug development, innovators are increasingly prioritizing patient-friendly dosage forms, such as ODTs, from the early stages of drug design. ODTs offer convenience and ease of administration, along with addressing concerns about dysphagia and enhancing patient compliance. This event will provide you with a unique opportunity to meet face-to-face with the Catalent team to learn more about how we can help accelerate your product’s potential with Zydis ODT. Schedule a meeting with Michael Sarmento or David Sebesta, Senior Directors, Zydis ODT, to learn more.  


WE LOOK FORWARD TO SEEING YOU IN BOSTON 
 

The Alzheimer’s & Parkinson’s Drug Development Summit is an industry-focused meeting dedicated to sharing AD & PD research from early discovery through to late phase trials and approvals. Join Catalent in Boston at this industry networking event dedicated to developing efficacious neurodegenerative drugs which will successfully slow, cure and prevent neurodegeneration.